# Ground Truth Medical Form (GTMF)

## Patient Information

- **Subject ID**: 24401
- **Admission ID**: 181551
- **Row ID**: 17135
- **Profile Type**: FULL

## Demographics

- **Age**: 70
- **Sex**: M
- **Date of Birth**: 2045-09-12
- **Ethnicity**: WHITE
- **Marital Status**: MARRIED
- **Religion**: CATHOLIC
- **Insurance**: Medicare
- **Admission Type**: EMERGENCY
- **Admission Date**: 2115-11-07 16:13:00
- **Discharge Date**: 2115-11-16 15:00:00

## Chief Complaint

hypertensive emergency

## Symptoms

- **hypertension (blood pressure in 220s/110s)** | onset: following esophageal stent placement
- **bilious vomiting (150 cc, vomited x3 overnight)** | onset: post-procedure | duration: overnight
- **umbilical pain (cramping, mild, minimal tenderness)** | onset: post-procedure | severity: mild
- **frontal headache** | onset: post-procedure | duration: improved at time of exam
- **nausea** | onset: post-procedure | duration: overnight
- **chronic shortness of breath** | onset: chronic | severity: not significantly changed from baseline
- **hypertension** | onset: night of admission
- **mild nausea** | onset: night of admission | severity: mild
- **abdominal pain** | onset: initially after admission | duration: persisted after transfer, resolved by discharge
- **diminished vision** | onset: after return to medical floor

## Medical History

1) Distal esophageal stricture s/p multiple balloon dilations 2) colonic adenoCa s/p hemicolectomy 3) ventral hernia 4) s/p CVA 5) CAD s/p MI with stent placement (2112) 6) PVD 7) COPD 8) PUD

## Allergies

Penicillins

## Current Medications

- **lansoprazole** | purpose: Gastric acid suppression

## Discharge Medications

- **glargine**
- **Lansoprazole 30 mg Tablet, Rapid Dissolve, DR** | dosage: Two (2) Tablet, Rapid Dissolve, DR twice a day | frequency: twice a day
- **Finasteride 5 mg Tablet** | dosage: One (1) Tablet PO DAILY | frequency: Daily
- **Atorvastatin 20 mg Tablet** | dosage: One (1) Tablet PO DAILY | frequency: Daily
- **Albuterol 90 mcg/Actuation Aerosol** | dosage: 1-2 Puffs Inhalation Q6H as needed | frequency: every 6 hours as needed
- **Fluticasone-Salmeterol 100-50 mcg/Dose Disk with Device** | dosage: One (1) Disk with Device Inhalation 2 times a day | frequency: 2 times a day
- **Lisinopril 20 mg Tablet** | dosage: One (1) Tablet PO DAILY | frequency: Daily
- **Simethicone 80 mg Tablet, Chewable** | dosage: One (1) Tablet, Chewable PO QID as needed | frequency: 4 times a day as needed
- **Clopidogrel 75 mg Tablet** | dosage: One (1) Tablet PO DAILY | frequency: Daily
- **Metoprolol Tartrate 50 mg Tablet** | dosage: One (1) Tablet PO BID | frequency: 2 times a day
- **Metronidazole 500 mg Tablet** | dosage: One (1) Tablet PO TID for 5 days | frequency: 3 times a day for 5 days
- **Aluminum-Magnesium Hydroxide 225-200 mg/5 mL Suspension** | dosage: 15-30 MLs PO QID as needed | frequency: 4 times a day as needed
- **Glargine** | dosage: Twenty (20) units at bedtime | frequency: at bedtime
- **Ultra One Glucometer** | dosage: One (1) meter before meals and bedtime | frequency: before meals and bedtime
- **Glucose strips for glucometer** | dosage: One (1) glucose strips QACHS and QHS | frequency: QACHS and QHS
- **Insulin Syringes (Disposable) Syringe** | dosage: One (1) syringe QACHS and QHS | frequency: QACHS and QHS
- **Humalog Insulin** | dosage: One (1) dose QACHS and QHS | frequency: QACHS and QHS

## Diagnoses

- **hypertensive emergency** | notes: presenting diagnosis
- **Large ventral hernia including large and small loops of bowel** | notes: No evidence for acute obstruction; partial obstruction cannot be excluded
- **History of esophagitis with circumferentially thickened esophageal walls** | notes: Neoplasm cannot be excluded based on imaging findings
- Right kidney stone
- **Small ill-defined pulmonary subcentimeter consolidations/nodules** | notes: Attention can be paid on followup exams
- Extensive calcification in the aorta and iliac arteries bilaterally, and SMA
- **Hypoattenuating contour deformity in the left kidney** | notes: Renal ultrasound could be helpful in further evaluating this area
- **Diabetic ketoacidosis (DKA)** | notes: Unusual presentation, no prior DM history, A1C 15.2
- **Hypertension** | notes: Hypertensive urgency post-procedure, resolved with IV lopressor
- **Esophageal stricture s/p stent** | notes: Continued on home lansoprazole
- **Cataracts** | notes: Diminished vision likely due to blood sugar associated-fluid shifts in diagnosed cataracts
- **COPD** | notes: Patient continued on home combivent and started on advair during admission.
- **CAD** | notes: Patient continued on home metoprolol, plavix, and lipitor.
- **diabetic ketoacidosis** | notes: Primary discharge diagnosis
- **chronic obstructive pulmonary disease** | notes: Secondary discharge diagnosis
- **colonic adenocarcinoma** | notes: Secondary discharge diagnosis
- **distal esophageal stricture** | notes: Secondary discharge diagnosis
- **peripheral vascular disease** | notes: Secondary discharge diagnosis

## Treatment Options

### esophageal stent placement

**Details**: performed prior to admission

### antihypertensive therapy

**Details**: IV medications given for blood pressure control
**Treatment**: 2.5 mg IV lopressor, 10 mg IV hydralazine (x2 doses)

**Medications**:
- lopressor (2.5 mg IV)
- hydralazine (10 mg IV)

### Imaging follow-up

**Details**: Re-scanning of the patient can be performed if clinical concern for obstruction persists; renal ultrasound could be helpful for left kidney abnormality

### IV lopressor

**Details**: Used for hypertensive urgency post-stent placement
**Treatment**: Blood pressure control

**Medications**:
- IV lopressor (not provided)

### Insulin sliding scale (ISS) and glargine

**Details**: ISS protocol and glargine at discharge for DKA/hyperglycemia
**Treatment**: Blood sugar control

**Medications**:
- glargine (not provided)

### Lansoprazole

**Details**: Continued at home dose for esophageal stricture
**Treatment**: Gastric acid suppression

**Medications**:
- lansoprazole (not provided)

### Medication management

**Details**: Continuation and adjustment of home and new medications for COPD and CAD.

**Medications**:
- Combivent (not provided)
- Advair (not provided)
- Metoprolol (not provided)
- Plavix (not provided)
- Lipitor (not provided)

### Dietary management

**Details**: Advanced to low sodium/cardiac healthy/DM diet once able to tolerate PO.

### Electrolyte repletion

**Details**: Electrolytes repleted as necessary.

### Prophylaxis

**Details**: Patient placed on lansoprazole, heparin SC, and additional regimen.

**Medications**:
- Lansoprazole (not provided)
- Heparin SC (not provided)

### Homecare with service

**Details**: Discharged home with homecare services

### Insulin administration

**Details**: Patient instructed to check fingersticks before each meal and at bedtime and administer insulin as directed.
**Treatment**: Insulin therapy
